POTENTIATION BY DEPRENIL OF L-DOPA INDUCED CIRCLING IN NIGRAL-LESIONED RATSHEIKKILA RE; CABBAT FS; MANZINO L et al.1981; PHARMACOL., BIOCHEM. BEHAV.; ISSN 0091-3057; USA; DA. 1981; VOL. 15; NO 1; PP. 75-79; BIBL. 17 REF.Article

THE MONOAMINE OXIDASES OF BRAIN: SELECTIVE INHIBITION WITH DRUGS AND THE CONSEQUENCES FOR THE METABOLISM OF THE BIOGENIC AMINES = LES MONOAMINE-OXYDASES DU CERVEAU: INHIBITION SELECTIVE PAR LES MEDICAMENTS ET CONSEQUENCES POUR LE METABOLISME DES AMINES BIOGENESYANG HYT; NEFF NH.1974; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1974; VOL. 189; NO 3; PP. 733-740; BIBL. 23REF.Article

DOPAMINE OXIDATION AND ITS INHIBITION BY (-)-DEPRENYL IN MANGLOVER V; ELSWORTH JD; SANDLER M et al.1980; J. NEUR. TRANSM., SUPPL.; AUT; DA. 1980; NO 16; PP. 163-172; BIBL. 2 P.Article

TITRATION OF HUMAN BRAIN MONOAMINE OXIDASE-A AND -B BY CLORGYLINE AND L-DEPRENILFOWLER CJ; ORELAND L; MARCUSSON J et al.1980; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; DEU; DA. 1980; VOL. 311; NO 3; PP. 263-272; BIBL. 2 P.Article

THE REACTION OF BOVINE AND RAT LIVER MONOAMINE OXIDASE WITH (¹⁴C)-CLORGYLINE AND (¹⁴C)-DEPRENYLSALACH JI; DETMER K; YOUDIM MBH et al.1979; MOLEC. PHARMACOL.; USA; DA. 1979; VOL. 16; NO 1; PP. 234-241; BIBL. 25 REF.Article

NOVEL (-) DEPRENYL-DERIVED SELECTIVE INHIBITORS OF B-TYPE MONOAMINE OXIDASE: THE RELATION OF STRUCTURE TO THEIR ACTIONKNOLL J; ECSERY Z; MAGYAR K et al.1978; BIOCHEM. PHARMACOL.; GBR; DA. 1978; VOL. 27; NO 13; PP. 1739-1747; BIBL. 44 REF.Article

THE EFFECT OF SELECTIVE MAD INHIBITORS ON THE CONDITIONED AVOIDANCE RESPONSE OF WISTAR RATS.KNOLL B; HELD G; GYARMATI Z et al.1977; POLISH J. PHARMACOL. PHARM.; POLAND; DA. 1977; VOL. 29; NO 3; PP. 291-296; ABS. POL.; BIBL. 12 REF.Article

THE MONOAMINE OXIDASE B INHIBITOR DEPRENYL POTENTIATES PHENYLETHYLAMINE BEHAVIOUR IN RATS WITHOUT INHIBITION OF CATECHOLAMINE METABOLITE FORMATION.BRAESTRUP C; ANDERSEN H; RANDRUP A et al.1975; EUROP. J. PHARMACOL.; NETHERL.; DA. 1975; VOL. 34; NO 1; PP. 181-187; BIBL. 1 P. 1/2Article

DEPRENYL DOES NOT CAUSE INSOMNIA IN PARKINSONIAN PATIENTSLAVIE P; WAJSBORT J; YOUDIM MBH et al.1980; COMMUN. PSYCHOPHARMACOL.; ISSN 0145-5699; GBR; DA. 1980 PUBL. 1981; VOL. 4; NO 4; PP. 303-307; BIBL. 16 REF.Article

DOPAMINE METABOLISM IN HUMAN BRAIN: EFFECTS OF MONOAMINE OXIDASE INHIBITION IN VITRO BY (-) DEPRENYL AND (+) AND (-) TRANYLCYPROMINEREYNOLDS GP; RIEDERER P; RAUSCH WD et al.1980; J. NEUR. TRANSM., SUPPL.; AUT; DA. 1980; NO 16; PP. 173-178; BIBL. 14 REF.Article

Changes in dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in human cerebrospinal fluid after L-dopa and deprenyl administrationBARACZKA, K; FEKETE, M. I. K; KANYICSKA, B et al.Journal of neural transmission. 1983, Vol 58, Num 3-4, pp 299-304, issn 0300-9564Article

MONOAMINE OXIDASE ACTIVITY IN SEVERAL TISSUES OF THE GOLDFISH, CARASSIUS AURATUSHALL TR; URUENA G.1982; COMP. BIOCHEM. PHYSIOL., C COMP. PHARMACOL.; ISSN 0306-4492; GBR; DA. 1982; VOL. 71; NO 2; PP. 145-147; BIBL. 19 REF.Article

INHIBITION OF MONOAMINE OXIDASE BY CLORGYLINE AND DEPRENYL IN CIRCUMVENTRICULAR STRUCTURES OF RAT BRAINKINEMUCHI H; WAKUI Y; ARAI Y et al.1980; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1980; VOL. 29; NO 20; PP. 2871-2874; BIBL. 28 REF.Article

L-DEPRENYL, A SELECTIVE MONOAMINE OXIDASE TYPE-B INHIBITOR IN ENDOGENOUS DEPRESSIONMANN J; GERSHON S.1980; LIFE SCI.; GBR; DA. 1980; VOL. 26; NO 11; PP. 877-882; BIBL. 23 REF.Article

THE EFFECT OF DEPRENYL, A SELECTIVE MONOAMINE OXIDASE B INHIBITOR, ON SLEEP AND MOOD IN MANTHORNTON C; DORE CJ; ELSWORTH JD et al.1980; PSYCHOPHARMACOLOGY; DEU; DA. 1980; VOL. 70; NO 2; PP. 163-166; BIBL. 21 REF.Article

DEPRENYL IS METABOLIZED TO METHAMPHETAMINE AND AMPHETAMINE IN MANREYNOLDS GP; ELSWORTH JD; BLAU K et al.1978; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1978; VOL. 6; NO 6; PP. 542-544; BIBL. 18 REF.Article

COMBINATION TREATMENT WITH SELECTIVE MONOAMINE OXIDASE INHIBITORS AND DOPAMINERGIC AGONISTS IN PARKINSON'S DISEASE: BIOCHEMICAL AND CLINICAL OBSERVATIONSRIEDERER P; JELLINGER K; DANIELCZYK W et al.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 159-176; BIBL. 81 REF.Article

Enhancer regulation/endogenous and synthetic enhancer compounds: A neurochemical concept of the innate and acquired drivesKNOLL, Joseph.Neurochemical research. 2003, Vol 28, Num 8, pp 1275-1297, issn 0364-3190, 23 p.Article

Mysterious MAOI hypertensive episodesLINET, L. S.The Journal of clinical psychiatry. 1986, Vol 47, Num 11, pp 563-565, issn 0160-6689Article

CLORGYLINE AND DEPRENYL INSENSITIVE MONOAMINE OXIDASE IN RAT BRAIN SOLUBLE FRACTIONCHANDRA SHEKHAR; MAYANIL K; BAQUER NZ et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 23; PP. 3925-3927; BIBL. 9 REF.Article

DEPRENYL IN PARKINSON'S DISEASE.LEES AJ; SHAW KM; KOHOUT LJ et al.1977; LANCET; G.B.; DA. 1977; NO 8042; PP. 791-795; BIBL. 18 REF.Article

AMPHETAMINE, P-HYDROXYAMPHETAMINE AND BETA -PHENETHYLAMINE IN MOUSE BRAIN AND URINE AFTER (-)- AND (+)-DEPRENYL ADMINISTRATIONPHILIPS SR.1981; J. PHARM. PHARMACOL.; ISSN 0022-3573; GBR; DA. 1981; VOL. 33; NO 11; PP. 739-741; BIBL. 17 REF.Article

CHARACTERIZATION OF N-METHYPHENYLETHYLAMINE AND N-METHYLPHENYLETHANOLAMINE AS SUBSTRATES FOR TYPE A AND TYPE B MONOAMINE OXIDASESUZUKI O; OYA M; KATSUMATA Y et al.1980; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1980; VOL. 29; NO 19; PP. 2663-2667; BIBL. 20 REF.Article

THE MONOAMINE OXIDASE INHIBITORS CLORGYLINE AND L-DEPRENYL ALSO AFFECT THE UPTAKE OF DOPAMINE, NORADRENALINE AND SEROTONIN BY RAT BRAIN SYNAPTOSOMAL PREPARATIONSLAI JCK; LEUNG TKC; GUEST JF et al.1980; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1980; VOL. 29; NO 20; PP. 2763-2767; BIBL. 19 REF.Article

INFLUENCE OF MAO-INHIBITORS ON DEAMINATION OF ³H-NOREPINEPHRINE IN THE DOG'S SAPHENOUS VEIN.VERBEUREN TJ; VANHOUTTE PM.1978; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1978; VOL. 232; NO 2; PP. 348-349; BIBL. 3 REF.Article